Loading data
ACMRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 901.31 m USD | 782.12 m USD | 557.72 m USD | 388.83 m USD | 259.75 m USD |
| Cost of revenue | 501.24 m USD | 390.56 m USD | 281.51 m USD | 205.22 m USD | 144.9 m USD |
| Gross profit | 400.07 m USD | 391.55 m USD | 276.22 m USD | 183.62 m USD | 114.86 m USD |
| Research and development expense | 144.99 m USD | 105.47 m USD | 92.71 m USD | 62.23 m USD | 34.21 m USD |
| Operating profit | 109.43 m USD | 151 m USD | 95.84 m USD | 59.04 m USD | 38.7 m USD |
| Interest expense | — | — | 2.68 m USD | 1.66 m USD | 765 k USD |
| Profit before tax | 135.19 m USD | 166.3 m USD | 116.22 m USD | 67.36 m USD | 43.06 m USD |
| Income tax expense | 13.3 m USD | 35.03 m USD | 19.36 m USD | 16.8 m USD | 134 k USD |
| Net income (reported basis) | 94.08 m USD | 103.63 m USD | 77.35 m USD | 39.26 m USD | 43 m USD |
| Net income attributable to common shareholders | 94.08 m USD | 103.63 m USD | 77.35 m USD | 39.26 m USD | 37.76 m USD |
| Basic earnings per share | 1.47 USD/share | 1.67 USD/share | 1.29 USD/share | 0.66 USD/share | 0.65 USD/share |
| Diluted earnings per share | 1.37 USD/share | 1.53 USD/share | 1.16 USD/share | 0.59 USD/share | 0.58 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.